PUBLICATIONS DES MEMBRES

2014 update of the GEFPICS' recommendations for HER2 status determination in breast cancers in France
2015 - Penault-Llorca F,Vincent-Salomon A,MacGrogan G,Roger P,Treilleux I, Valent A,Mathieu MC,Antoine M,Becette V,Bor C,Brabencova E,Charafe-Jauffret E,Chenard MP,Dauplat MM,Delrée P,Devouassoux M,Fiche M, ondrevelle ME,Fridman V,Garbar C,Genin P,Ghnassia JP,Haudebourg J,Laberge-Le Couteulx S,Loussouarn D,Maran-Gonzalez A,Marcy M,Michenet P,Poulet B,Sagan C,Trassard M,Verriele V,Arnould L,Lacroix-Triki M;GEFPICS Ann Pathol n°34 - pp 352-365
A bivalent role of TIP60 histone acetyl transferase in human cancer
2015 - Judes G,Rifai K,Ngollo M,Daures M,Bignon YJ,Penault-Llorca F,Bernard-Gallon D Epigenomics n°7 - pp 1
A novel autosomal dominant leukodystrophy with specific MRI pattern
2015 - Corlobe A,Taithe F,Clavelou P,Pierre E,Carra-Dalliere C,Ayrignac X,Mouzat K,Lumbroso S,MenjotdeChampfleur N,Koenig M,Boespflug-Tanguy O,Labauge P J Neurol n°Feb 17 - pp 1
Airborne pollen levels and drug consumption for seasonal allergic rhinoconjunctivitis: a 10-year study in France
2015 - Caillaud DM,Martin S,Segala C,Vidal P,Lecadet J,Pellier S,Rouzaire P,Tridon A,Evrard B Allergy n°70(1) - pp 99-106
An international study to increase concordance in Ki67 scoring
2015 - Polley MY,Leung SC,Gao D,Mastropasqua MG,Zabaglo LA,Bartlett JM,McShane LM,Enos RA,Badve SS,Bane AL,Borgquist S,Fineberg S,Lin MG,Gown AM,Grabau D,Gutierrez C,Hugh JC,Moriya T,Ohi Y,Osborne CK,Penault-Llorca FM,Piper T,Porter PL,Sakatani T,Salgado R,Starczynski J,Laenkholm AV,Viale G,Dowsett M,Hayes DF,Nielsen TO Mod pathol n°Feb 20 - pp 1
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers
2015 - Blein S,Bardel C,Danjean V,Bignon YJ,Cox DG Breast Cancer Res n°17 - pp 61
Anatomoclinical study of ovarian cancers in patients with history of hysterectomy for benign pathology
2015 - Cornou C,Philippe AC,Le Bouedec G,Dauplat MM,Dauplat J,Pomel C J gynecol Obstet Biol Reprod n°27 - pp 1
Application of BCI systems in neurorehabilitation: a scoping review
2015 - Bamdad M,Zarshenas H,Auais MA Disabil Rehabil Assist Technol n°10 - pp 355-364
Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers
2015 - Blanco I,Kuchenbaecker K,Cuadras D,Berthet P,Cornelis F,Bignon YJ,Damiola F,Mazoyer S,Sinilnikova OM,Maxwell CA,Vijai J,Robson M,Kauff N,Corines MJ,Villano D,Cunningham J,Lee A,Lindor N,Lazaro C,Easton DF,Offit K,Chenevix-Trench G,Couch FJ,Antoniou AC,Pujana MA PLoS One n°10 - pp 1
BRCA Genetic Screening in Middle Eastern and North African: Mutational Spectrum and Founder BRCA1 Mutation (c.798_799delTT) in North African
2015 - Laraqui A,Uhrhammer N,Elrhaffouli H,Sekhsokh Y,Lahlou-Amine I,Bajjou T,Hilali F,Elbaghadi J,Albouzidi A,Bakri Y,Amzazi S,Bignon YJ Dis Markers n°28 - pp 1
BRCA mutations increase fertility in families at hereditary breast/ovarian cancer risk
2015 - Kwiatkowski F,Arbre M,Bidet Y,Laquet C,Uhrhammer N,Bignon YJ PLoS One n°10(6) - pp 1
BRCA1 and BRCA2 Mutations in Ethnic Lebanese Arab Women With High Hereditary Risk Breast Cancer
2015 - Elsaghir NS,Zgheib NK,Assi HA,Khoury KE,Bidet Y,Jaber SM,Charafa RN,Farhat RA,Kreidieh FY,Decousus S,Romero P,Nemer GM,Salem Z,Shamseddine A,Tfayli A,Abbas J,Jamali F,Seoud M,Armstrong DK,Bignon YJ,Uhrhammer N Oncologist n°16 - pp 1
Breast Cancer Risk Associated with Estrogen Exposure and Truncating Mutation Location in BRCA1/2 Carriers
2015 - Lecarpentier J,Nogues C,Mouret-Fourme E,Buecher B,Gauthier-Villars M,Stoppa-Lyonnet D,Bonadona V,Fricker JP,Berthet P,Caron O,Coupier I,Pujol P,Faivre L,Gesta P,Eisinger F,Mari V,Gladieff L,Lortholary A,Luporsi E,Leroux D,Venat-Bouvet L,Maugard CM,Colas C,Tinat J,Lasset C,Andrieu N,GENEPSO Cancer Epidemiol Biomarkers Prev n°24 - pp 698-707
Can pathologic complete response (pCR) be used as a surrogate marker of survival after neoadjuvant therapy for breast cancer?
2015 - Wang-Lopez Q,Chalabi N,Abrial C,Radosevic-Robin N,Durando X,Mouret-Reynier MA,Benmammar KE,Kullab S,Bahadoor M,Chollet P,Penault-Llorca F,Nabholtz JM Crit Rev Oncol Hematol n°4 - pp 17
Cellular Expression of Cyclooxygenase, Aromatase, Adipokines, Inflammation and Cell Proliferation Markers in Breast Cancer Specimen
2015 - Basu S,Combe K,Kwiatkowski F,Caldefie-Chezet F,Penault-Llorca F,Bignon YJ,Vasson MP PLoS One n°10 - pp 1
Characteristics of a molybdenum X-pinch X-ray source as a probe source for X-ray diffraction studies
2015 - Zucchini F,Bland SN,Chauvin C,Combes P,Sol D,Loyen A,Roques B,Grunenwald J Rev SCi Instrum n°86 - pp 1
Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients
2015 - Semeraro M,Rusakiewicz S,Minard-Colin V,Delahaye NF,Enot D,Vely F,Marabelle A,Papoular B,Piperoglou C,Ponzoni M,Perri P,Tchirkov A,Matta J,Lapierre V,Shekarian T,Valsesia-Wittmann S,Commo F,Prada N,Poirier-Colame V,Bressac B,Cotteret S,Brugieres L,Farace F,Chaput N,Kroemer G,Valteau-Couanet D,Zitvogel L Sci Transl Med n°283 - pp 1
Combination of mTOR and EGFR targeting in an orthotopic xenograft model of head and neck cancer
2015 - Bozec A,Ebran N,Radosevic-Robin N,Sudaka A,Monteverde M,Toussan N,Etienne-Grimaldi MC,Nigro CL,Merlano M,Penault-Llorca F,Milano G Laryngoscope n°24 - pp 1
Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer
2015 - Ladoire S,Penault-Llorca F,Senovilla L,Dalban C,Enot D,Locher C,Prada N,Poirier-Colame V,Chaba K,Arnould L,Ghiringhelli F,Fumoleau P,Spielmann M,Delaloge S,Poillot ML,Arveux P,Goubar A,Andre F,Zitvogel L,Kroemer G Autophagy n°11 - pp 1878-90
Commercially available genomic based signatures in early breast cancer: Is it ready for tomorrow morning?
2015 - Goncalves A,Penault-Llorca F Bull Cancer n°102(6) - pp 1